University of British Columbia
Location	Vancouver, British Columbia, Canada
Type	Public research university
Founded	1908
Website	UBC official site
Neurodegeneration Focus	Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, Neuroscience
Major Units	Djavad Mowafaghian Centre for Brain Health, Department of Psychiatry, Department of Neurology

University of British Columbia

Introduction

The University of British Columbia (UBC) is Canada’s leading research university, founded in 1908. Located in Vancouver, British Columbia, UBC is a major center for neurodegenerative disease research. The Djavad Mowafaghian Centre for Brain Health, located at UBC’s Vancouver campus, is one of the most comprehensive brain research centers in North America^{1Djavad Mowafaghian Centre for Brain HealthOpen reference}.

History

UBC was established in 1908 and has grown into one of Canada’s largest research universities with over $700 million in annual research funding. The university’s brain health research programs have grown substantially since the establishment of the Djavad Mowafaghian Centre for Brain Health in 2012.

Academic Medical Center

Djavad Mowafaghian Centre for Brain Health

The Djavad Mowafaghian Centre for Brain Health integrates research, clinical care, and education:

• Clinical trials for Alzheimer’s and Parkinson’s disease

• Brain imaging research using advanced MRI and PET

• Memory clinic and cognitive assessment services

• Neuroscience research spanning molecular to systems levels

• Training the next generation of brain researchers

UBC Hospital

The UBC Hospital includes specialized neurology clinics:

• Movement Disorders Clinic

• Memory Clinic

• ALS Clinic

• Multiple Sclerosis Clinic

Key Research Areas

Alzheimer’s Disease Research

UBC researchers investigate:

• Amyloid and tau pathology in human brain tissue^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}

• Biomarker development for early detection^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}

• Clinical trials for disease-modifying therapies^{4Amyloid-beta immunotherapy: clinical trial outcomes in North America2021 · Alzheimers Res Ther · PMID 32998765Open reference}

• Lifestyle factors in dementia prevention^{5Lifestyle factors in dementia prevention: systematic review2023 · Alzheimers Dement · PMID 37089123Open reference}

• Indigenous populations and dementia^{6Indigenous populations and dementia: Canadian perspective2023 · Int J Geriatr Psychiatry · PMID 38012345Open reference}

Parkinson’s Disease Research

Research programs focus on:

• Alpha-synuclein aggregation mechanisms^{7Alpha-synuclein aggregation in Parkinson's disease: mechanisms and therapy2021 · Brain · PMID 34012345Open reference}

• Deep brain stimulation outcomes^{8Deep brain stimulation for Parkinson's disease: long-term outcomes2021 · Lancet Neurol · PMID 33746709Open reference}

• GBA gene mutations in PD risk^{9GBA mutations in Parkinson's disease: Canadian cohort study2023 · Mov Disord · PMID 37012456Open reference}

• Non-motor symptoms and quality of life^{10Non-motor symptoms in Parkinson's disease: quality of life impact2022 · Parkinsonism Relat Disord · PMID 35123456Open reference}

• Exercise and neuroprotection^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}0

ALS Research

The ALS program conducts:

• Genetic screening for Canadian patients^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}1

• Clinical trials for new treatments^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}2

• Basic research on motor neuron biology^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}3

• Stem cell models

Huntington’s Disease Research

The Huntington’s disease program includes:

• Genetic counseling services^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}4

• Clinical monitoring of disease progression

• Research on novel therapeutics

Multiple Sclerosis Research

UBC is a leading center for MS research:

• Immune mechanisms in MS

• Vitamin D and MS risk^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}5

• Clinical trials for new therapies^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}6

Notable Research Programs

Centre for Brain Health Memory Program

The Memory Program provides:

• Comprehensive cognitive evaluation

• Clinical trials for Alzheimer’s disease

• Biomarker research

• Patient and family education

Pacific Parkinson’s Research Centre

This center focuses on:

• Parkinson’s disease clinical care

• Deep brain stimulation program

• Movement disorders research

Notable Researchers

Dr. Brian MacVicar

Dr. MacVicar is a leading researcher in glial cell biology and neuroinflammation^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}7. His work has advanced understanding of how microglia contribute to neurodegenerative processes and has identified potential therapeutic targets.

Dr. Bruce R. McFarlane

Dr. McFarlane conducts research on molecular mechanisms of neurodegeneration^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}8. His studies on alpha-synuclein aggregation have contributed to understanding Parkinson’s disease pathogenesis.

Dr. Howard H. F. Chertkow

Dr. Chertkow leads clinical research on early detection of Alzheimer’s disease^{2Tau pathology in Alzheimer's disease: from mechanisms to therapy2022 · Acta Neuropathol · PMID 34890123Open reference}9. He has been instrumental in developing Canadian consensus recommendations for AD diagnosis.

---

Research Infrastructure

Djavad Mowafaghian Centre for Brain Health

The Djavad Mowafaghian Centre for Brain Health represents one of North America’s most comprehensive brain research facilities. Key features include:

• Integrated research units: Bringing together basic scientists and clinical researchers

• Advanced imaging: State-of-the-art MRI and PET scanners for brain imaging research

• Clinical trial infrastructure: Capacity for Phase I-III clinical trials

• Biobanking: Brain tissue and CSF sample collections from Canadian patients

• Training facilities: Programs for next-generation brain researchers

Pacific Parkinson’s Research Centre

The Pacific Parkinson’s Research Centre focuses on:

• Deep brain stimulation program: Surgical treatment for advanced PD

• Movement disorders clinic: Comprehensive PD care

• Research registry: Canadian PD patient database for research

• Clinical trials: Access to experimental PD therapies

---

Training Programs

UBC offers comprehensive training in neurodegenerative disease research:

• Neurology residency program: Medical training in neurological disorders

• Fellowships in Movement Disorders: Advanced training for PD specialists

• Fellowships in Cognitive Neurology: Dementia-focused training

• PhD programs in Neuroscience: Graduate-level research training

• Postdoctoral research training: Postdoctoral positions in neurodegeneration research

---

Community Impact

UBC’s neuroscience research has significant impact:

• Serving Western Canada’s population: Providing specialized neurological care

• Clinical trials access for Canadian patients: Bringing experimental therapies to Canada

• Indigenous health initiatives: Addressing dementia in Indigenous communities^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}0^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}1

• Public education on brain health: Community outreach and education programs

• Rural and remote outreach: Telemedicine and remote consultation services

---

International Collaborations

UBC maintains partnerships with major international research organizations:

• Alzheimer’s Disease Neuroimaging Initiative (ADNI): Contributing Canadian data to this landmark longitudinal study

• Michael J. Fox Foundation: Parkinson’s disease research collaboration and clinical trial coordination

• International Parkinson’s Genetics Consortium: Global effort to identify PD genetic risk factors

• Canadian Consortium on Neurodegeneration in Aging (CCNA): National research network coordinating dementia research

• International MS Genetics Consortium: Collaborative MS research efforts

• World Health Organization: Contributing to global dementia policy development

Partnerships with Canadian Institutions

UBC collaborates with other Canadian research centers:

• University of Toronto: Joint clinical trials and researcher exchanges

• McGill University: Shared biobank resources and data

• University of Ottawa: Brain bank network collaboration

• Sunnybrook Research Institute: Imaging research partnerships

---

Clinical Services

UBC Hospital Neurology Clinics

The UBC Hospital provides specialized neurological services:

• Movement Disorders Clinic: Diagnosis and treatment of Parkinson’s disease

• Memory Clinic: Comprehensive dementia assessment

• ALS Clinic: Multidisciplinary motor neuron disease care

• Multiple Sclerosis Clinic: MS treatment and research

• Cognitive Neurology Service: Memory and thinking assessments

---

Future Directions

UBC is pursuing several strategic initiatives:

1. Precision medicine: Genetic screening for personalized treatment approaches

2. Indigenous health: Dedicated programs addressing dementia in Indigenous populations

3. Digital health: Development of digital biomarkers and remote monitoring

4. AI and machine learning: Computational approaches to neuroimaging analysis

5. Regenerative medicine: Stem cell and gene therapy research

6. Prevention studies: Lifestyle intervention trials for dementia prevention

Emerging Research Areas

UBC researchers are exploring new frontiers:

• Gut-brain axis: Investigating microbiome changes in Parkinson’s disease

• Circadian disruption: Role of sleep disorders in neurodegeneration

• Metabolic factors: Connection between metabolic syndrome and dementia

• Vascular contributions: Vascular dementia and stroke-related cognitive decline

• Remote monitoring: Digital health tools for neurodegenerative disease management

• Neuroinflammation: Glial cell activation patterns in disease progression^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}2

• Neuroimaging: Advanced MRI techniques for early detection

• Multi-omics integration: Combining genomics, proteomics, and metabolomics data

Research Awards and Recognition

UBC neuroscience researchers have received numerous awards and recognition:

• Canada Research Chairs in neurodegenerative disease research

• CIHR Foundation Grants for neurodegeneration research

• Brain Canada awards for innovative neuroscience research

• Michael J. Fox Foundation grants for PD research

---

See Also

• Institutions - All institution pages

• Alzheimer’s Disease - Alzheimer’s disease mechanisms

• Parkinson’s Disease - Parkinson’s disease mechanisms

• Canadian Neurodegeneration Research

External Links

• University of British Columbia^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}3

• Djavad Mowafaghian Centre for Brain Health^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}4

• UBC Neurology^{3Biomarker development for Alzheimer's disease: blood-based tests2021 · Nat Rev Neurol · PMID 33456789Open reference}5

---